| Joram Sawady, MD | |
|
2500 Metrohealth Dr, Mhmc-pathology, Cleveland, OH 44109-1900 | |
| (216) 778-4943 | |
| Not Available |
| Full Name | Joram Sawady |
|---|---|
| Gender | Female |
| Speciality | Pathology - Anatomic Pathology |
| Location | 2500 Metrohealth Dr, Cleveland, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043240302 | NPI | - | NPPES |
| 0846786 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZC0500X | Pathology - Cytopathology | 35057970 (Ohio) | Secondary |
| 207ZP0101X | Pathology - Anatomic Pathology | 35057970 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joram Sawady, MD 2500 Metrohealth Dr, Mhmc-pathology, Cleveland, OH 44109-1900 Ph: (216) 778-4943 | Joram Sawady, MD 2500 Metrohealth Dr, Mhmc-pathology, Cleveland, OH 44109-1900 Ph: (216) 778-4943 |
News Archive
New lateral flow test Vigilant is cheaper, easier to use and as reliable as the current gold standard PCR test for diagnosing SARS-CoV-2 infection.
A team of scientists from Australia has recently identified a frameshift deletion mutation in ORF7a of the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The mutation results in the production of a truncated peptide with altered functionality. The study is currently available on the medRxiv* preprint server while awaiting peer review.
Zealand Pharma A/S, a biopharmaceutical company dedicated to the discovery and development of innovative peptide drugs, is pleased to announce that its partner, sanofi-aventis, today announced that the GetGoal-X Phase III study of lixisenatide, a once-daily GLP-1 receptor agonist licensed from Zealand Pharma, achieved its primary endpoint of non-inferiority in HbA1c reduction from baseline, compared with exenatide twice-daily.
Johns Hopkins researchers say they have confirmed suspicions that DNA modifications found in the blood of mice exposed to high levels of stress hormone — and showing signs of anxiety — are directly related to changes found in their brain tissues.
› Verified 4 days ago
Dr. Mary Katherine Allen-proctor, MD Pathology Medicare: May Accept Medicare Assignments Practice Location: 9500 Euclid Ave # Na-23, Cleveland, OH 44195 Phone: 216-444-2200 | |
Lan Zhou, MD Pathology Medicare: Medicare Enrolled Practice Location: 11100 Euclid Ave, Cleveland, OH 44106 Phone: 216-844-7494 Fax: 440-449-1555 | |
Dr. Sarah Ann White, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 11100 Euclid Ave, Rm 211b, Ms Pth 5077, Cleveland, OH 44106 Phone: 216-286-6590 | |
Dr. Ana Lucia Ruano Mendez, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave # L25, Cleveland, OH 44195 Phone: 216-444-6781 | |
Akeesha A Shah, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, L25, Cleveland, OH 44193 Phone: 216-636-9407 | |
Michael R Jacobs, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 11100 Euclid Ave, Cleveland, OH 44106 Phone: 216-844-7494 Fax: 216-286-6341 | |
Priscilla I Figueroa, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 800-223-2273 |